Study Stopped
recruitment too slow
Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair
1 other identifier
observational
30
1 country
1
Brief Summary
X-ray computed tomography imaging (CT) is routinely used in follow-up after endovascular aneurysm repair (EVAR). Contrast-enhanced ultrasound (CEUS) has been shown to give accurate information about endoleak after EVAR. Benefits of CEUS over CT include less radiation exposure, avoidance of renal function deterioration due to repeated X-ray contrast agent application and decrease in the cost of EVAR follow-up. This study is designed to investigate if results from literature are reproducible in St Olavs Hospital in Trondheim (Norway), to gain experience with the technique and to introduce CEUS as an alternative for detection of endoleak in this hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2013
CompletedFirst Posted
Study publicly available on registry
April 30, 2013
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedOctober 31, 2017
October 1, 2017
2.8 years
April 26, 2013
October 29, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection of endoleak with CEUS
Compare CEUS with computed tomography angiography (CTA) sensitivity for detection of endoleak
9 months
Eligibility Criteria
All patients in follow-up after endovascular implantation of abdominal aortic prothesis, Central Norway
You may qualify if:
- in follow-up after endovascular implantation of abdominal aortic prothesis
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
- SINTEF Health Researchcollaborator
Study Sites (1)
St Olavs Hospital
Trondheim, 7006, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Reidar Brekken, PhD
National Taiwan Normal University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2013
First Posted
April 30, 2013
Study Start
September 1, 2014
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
October 31, 2017
Record last verified: 2017-10